Estimating deep molecular responses in chronic myelogenous leukemia: a Bayesian approach

被引：0
|
作者：
S S Young
T Tucker
I Bosdet
A Karsan
机构：
[1] University of British Columbia,Department of Pathology and Laboratory Medicine
[2] Cancer Genetics Laboratory,Department of Pathology and Laboratory Medicine
[3] British Columbia Cancer Agency,undefined
来源：
Leukemia | 2016年 / 30卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1628 / 1629
页数：1
相关论文
共 50 条
  • [41] Chronic Myelogenous Leukemia
    Hasserjian, Robert P.
    CURRENT CANCER THERAPY REVIEWS, 2012, 8 (01) : 3 - 13
  • [42] The impact of sample processing delay on deep molecular responses in chronic myeloid leukemia
    Stephen E. Langabeer
    Mireille Crampe
    Tara Durney
    Irish Journal of Medical Science (1971 -), 2019, 188 : 351 - 352
  • [43] Deep molecular responses for treatment-free remission in chronic myeloid leukemia
    Dulucq, Stephanie
    Mahon, Francois-Xavier
    CANCER MEDICINE, 2016, 5 (09): : 2398 - 2411
  • [44] Demonstration of a chronic myelogenous leukemia clone in acute myelogenous leukemia
    Jeon, Byung Ryul
    Kim, Se Hyung
    Park, Sung Kyu
    Park, Rojin
    Hong, Dae Sik
    Lee, You Kyoung
    BIOMEDICAL RESEARCH-INDIA, 2016, 27 (04): : 1099 - 1101
  • [45] Pharmacotherapy for Chronic Myelogenous Leukemia: A Case-Based Approach
    Harnicar, Stephen
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2011, 9 : S25 - S35
  • [46] Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia.
    Kantarjian, H
    Sawyers, C
    Hochhaus, A
    Guilhot, F
    Schiffer, C
    Gambacorti-Passerini, C
    Niederwieser, D
    Resta, D
    Capdeville, R
    Zoellner, U
    Talpaz, M
    Druker, B
    NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (09): : 645 - 652
  • [47] Treatment patterns of chronic myelogenous leukemia patients with suboptimal responses to imatinib
    Guerin, A.
    Guo, A.
    Williams, D.
    Yu, A. P.
    Wu, E.
    Latremouille-Viau, D.
    Tsaneva, M.
    Signorovitch, J.
    Griffin, J. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [48] HOMOHARRINGTONINE THERAPY INDUCES RESPONSES IN PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA IN LATE CHRONIC PHASE
    OBRIEN, S
    KANTARJIAN, H
    KEATING, M
    BERAN, M
    KOLLER, C
    ROBERTSON, LE
    HESTER, J
    RIOS, M
    ANDREEFF, M
    TALPAZ, M
    BLOOD, 1995, 86 (09) : 3322 - 3326
  • [49] Optimizing Patient Care in Chronic Phase Chronic Myelogenous Leukemia: A Multidisciplinary Approach
    Sundar, Hema
    Radich, Jerald
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2016, 14 : S1 - S6
  • [50] MOLECULAR DIAGNOSTICS OF CHRONIC MYELOGENOUS LEUKEMIA AND PHILADELPHIA-POSITIVE ACUTE-LEUKEMIA
    KURZROCK, R
    SHTALRID, M
    GUTTERMAN, JU
    TALPAZ, M
    MOLECULAR DIAGNOSTICS OF HUMAN CANCER, 1989, 7 : 9 - 13
12345